0000899243-19-028704.txt : 20191206 0000899243-19-028704.hdr.sgml : 20191206 20191206172258 ACCESSION NUMBER: 0000899243-19-028704 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191206 FILED AS OF DATE: 20191206 DATE AS OF CHANGE: 20191206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schor Chen CENTRAL INDEX KEY: 0001340875 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38359 FILM NUMBER: 191273854 MAIL ADDRESS: STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC. STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: resTORbio, Inc. CENTRAL INDEX KEY: 0001720580 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813305277 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-482-2333 MAIL ADDRESS: STREET 1: 500 BOYLSTON STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-06 0 0001720580 resTORbio, Inc. TORC 0001340875 Schor Chen C/O RESTORBIO, INC. 500 BOYLSTON STREET, 13TH FLOOR BOSTON MA 02116 1 1 0 0 President and CEO Common Stock 2019-12-06 4 A 0 344000 0.00 A 669000 D Common Stock 1567363 I See Footnote Stock Option (Right to Buy) 1.27 2019-12-06 4 A 0 258000 0.00 A 2029-12-05 Common Stock 258000 258000 D The Reporting Person was issued Restricted Stock Units ("RSU"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in four (4) annual installments, with the first tranche vesting on December 6, 2020. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance. Represents 599,363 shares held directly by an irrevocable family trust having an independent trustee, 25,000 shares held by a revocable family trust of which the Reporting Person is the trustee, 643,000 shares held directly by an irrevocable family trust having an independent trustee, 25,000 shares held directly by a revocable trust of which the spouse is the trustee and 275,000 shares held directly by a grantor retained annuity trust of the spouse. 25% of the shares shall vest on December 6, 2020, with the remainder vesting in 36 equal monthly installments thereafter. /s/ Chen Schor 2019-12-06